Comprehensive intelligence on the PBM landscape. Regulatory actions, litigation, corporate structure, compliance, and industry trends delivered through a single searchable platform.
PBM Intel is a private intelligence platform that continuously monitors, collects, and analyzes publicly available information across the pharmacy benefit manager industry. Using automated web intelligence combined with AI-powered analysis, PBM Intel delivers structured, scored, and searchable intelligence on 35 of the most significant PBMs operating in the United States.
Updated monthly, PBM Intel tracks regulatory actions, litigation patterns, corporate changes, compliance issues, licensing activity, and industry-wide developments giving professionals a comprehensive, current view of the PBM landscape without hours of manual research.
Every intelligence item is analyzed and scored by AI trained on regulatory and examiner priorities so you see what matters most, instantly.
Each item is scored 1-10 for relevance. High-scoring items surface automatically so critical intelligence is never buried.
Direct integration with FTC, DOJ, SEC EDGAR, and CourtListener ensures primary source coverage alongside broader web intelligence.
Automated monthly scrapes keep the database current. New intelligence is added continuously and duplicates are never stored.
A dedicated industry intelligence feed tracks broad PBM landscape trends including legislation, enforcement patterns, and market developments.
Search across all intelligence by PBM name, topic, or keyword. Filter by category and sort by relevance or date.
State insurance departments, attorneys general offices, and federal agencies monitoring PBM compliance, enforcement trends, and market conduct.
Law firms handling PBM litigation, class actions, antitrust matters, and healthcare regulatory work requiring comprehensive background intelligence.
Healthcare consultants, pharmacy benefit advisors, and managed care professionals evaluating PBM performance, practices, and risk profiles.
Self-insured employers, Taft-Hartley funds, and HR consultants conducting vendor due diligence or monitoring their current PBM relationships.
Investors and private equity firms requiring intelligence on PBM regulatory exposure, litigation risk, and corporate structure for due diligence.
Health policy researchers, think tanks, and academics studying PBM market practices, regulatory outcomes, and industry consolidation trends.
PBM Intel is available by approval to qualified professionals. Complete the form below and we will be in touch.